FibroGen Reports Second Quarter 2025 Financial Results August 11, 2025 Forward-Looking Statements This presentation contains contains forward-looking statements regarding FibroGen's strategy, future plans and prospects, including statements regarding its commercial products and clinical programs and those of its collaboration partners Fortis and UCSF. These forward- looking statements include, but are not limited to, statements regarding the efficacy, safety, convenience, and potential clinical or commercia ...